Casdin Capital 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Casdin Capital disclosed 38 US equity positions worth $1.5bn in its Q4 2024 13F filing. The largest position was WGS at 18.0% of the reported book, followed by BLFS and RVMD. Against the Q3 2024 filing, it opened 5 new positions, added to 3 and reduced 5 among the top 38 holdings.
What did Casdin Capital own in Q4 2024? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | WGS GENEDX HOLDINGS CORP | Healthcare | 18.0% | $269.6m | 3,507,164 | 0% | held |
| 2 | BLFS BIOLIFE SOLUTIONS INC | Healthcare | 15.1% | $226.0m | 8,707,165 | 0% | held |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 10.8% | $161.8m | 3,699,283 | -10% | reduced |
| 4 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 8.7% | $130.5m | 1,073,500 | 0% | held |
| 5 | LAB STANDARD BIOTOOLS INC | Healthcare | 8.3% | $124.7m | 71,254,677 | 0% | held |
| 6 | ILMN ILLUMINA INC | Healthcare | 6.7% | $100.2m | 750,000 | 0% | held |
| 7 | AVIDITY BIOSCIENCES INC | 4.0% | $59.5m | 2,045,000 | -2% | reduced | |
| 8 | CDXS CODEXIS INC | Healthcare | 2.6% | $38.6m | 8,100,000 | 0% | held |
| 9 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.5% | $36.9m | 8,948,574 | -3% | reduced |
| 10 | EXK EXACT SCIENCES CORP | Basic Materials | 2.4% | $36.5m | 650,000 | 0% | held |
| 11 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 2.2% | $32.9m | 140,000 | -18% | reduced |
| 12 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.1% | $31.0m | 1,250,000 | 61% | added |
| 13 | NGNE NEUROGENE INC | 2.0% | $29.6m | 1,295,361 | 147% | added | |
| 14 | 2655787D BLUEPRINT MEDICINES CORP | 1.9% | $28.5m | 326,378 | 0% | held | |
| 15 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 1.6% | $23.3m | 2,000,000 | 0% | held |
| 16 | VERVE THERAPEUTICS INC | 1.5% | $22.5m | 3,995,571 | 0% | held | |
| 17 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.3% | $20.2m | 990,000 | 0% | held |
| 18 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.3% | $19.0m | 700,000 | 0% | held |
| 19 | SEPN SEPTERNA INC | 0.8% | $12.7m | 553,268 | – | new | |
| 20 | VCYT VERACYTE INC | Healthcare | 0.7% | $10.9m | 276,308 | -59% | reduced |
| 21 | GH GUARDANT HEALTH INC | Healthcare | 0.7% | $10.7m | 350,000 | 0% | held |
| 22 | TNYA TENAYA THERAPEUTICS INC | 0.6% | $9.6m | 6,732,971 | 0% | held | |
| 23 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.5% | $8.2m | 250,000 | – | new |
| 24 | MRNA MODERNA INC | Healthcare | 0.5% | $7.3m | 175,000 | – | new |
| 25 | 4D MOLECULAR THERAPEUTICS IN | 0.4% | $6.4m | 1,150,000 | 0% | held | |
| 26 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.4% | $6.3m | 475,000 | 0% | held |
| 27 | 2SEVENTY BIO INC | 0.4% | $5.9m | 2,000,000 | 0% | held | |
| 28 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.4% | $5.2m | 5,190,506 | 62% | added |
| 29 | FTRE FORTREA HLDGS INC | Healthcare | 0.3% | $5.1m | 275,000 | – | new |
| 30 | CTNM CONTINEUM THERAPEUTICS INC | 0.3% | $4.3m | 296,666 | 0% | held | |
| 31 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.2% | $3.7m | 1,188,349 | 0% | held |
| 32 | ABSI ABSCI CORPORATION | 0.2% | $2.5m | 973,260 | 0% | held | |
| 33 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 0.1% | $1.9m | 1,035,859 | 0% | held |
| 34 | RXRX RECURSION PHARMACEUTICALS IN | Healthcare | 0.1% | $1.1m | 165,323 | – | new |
| 35 | PRME PRIME MEDICINE INC | 0.1% | $1.1m | 367,175 | 0% | held | |
| 36 | GLUE MONTE ROSA THERAPEUTICS INC | 0.0% | $596.9k | 86,014 | 0% | held | |
| 37 | GINKGO BIOWORKS HOLDINGS INC | 0.0% | $358.4k | 36,493 | 0% | held | |
| 38 | KRONOS BIO INC | 0.0% | $117.6k | 123,839 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.